These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A symposium: Second International Conference on Hypercholesterolemia--examining new data on probucol after a decade of use. Am J Cardiol; 1988 Jul; 62(3):1B-81B. PubMed ID: 3394647 [No Abstract] [Full Text] [Related]
24. [A long-term (9 years) clinical study of the safety and efficacy of probucol, and an analysis of morbidity and mortality rates (author's transl)]. Tedeschi RE; Martz BL; Taylor HA; Cerimelle BJ Nouv Presse Med; 1980 Oct; 9(40):3021-7. PubMed ID: 7003530 [TBL] [Abstract][Full Text] [Related]
25. Probucol (Lorelco) in treatment of hyperlipemia. Murphy BF JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758 [TBL] [Abstract][Full Text] [Related]
26. [Comparative effect of probucol and clofibrate in patients with primary hypercholesterolemia]. Pasquali R; Melchionda N; Parenti M; Cavazzini MG; Biso P; Baraldi G; Sorrenti G; De Benedittis G; Labò G Clin Ter; 1982 Dec; 103(5):509-20. PubMed ID: 7160143 [No Abstract] [Full Text] [Related]
27. Probucol: a weak hypocholesterolemic agent. Mishkel MA; Crowther SM Can Med Assoc J; 1981 Jul; 125(2):135. PubMed ID: 7272863 [No Abstract] [Full Text] [Related]
28. [How do changes in the plasma concentration of HDL induced by probucol operate?]. Med Clin (Barc); 1988 Apr; 90(13):556-7. PubMed ID: 3393042 [No Abstract] [Full Text] [Related]
29. Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia. Buckley MM; Goa KL; Price AH; Brogden RN Drugs; 1989 Jun; 37(6):761-800. PubMed ID: 2667936 [TBL] [Abstract][Full Text] [Related]
30. Mode of hypocholesterolemic action of probucol in animals and man. Beynen AC Artery; 1987; 14(2):113-26. PubMed ID: 3551883 [TBL] [Abstract][Full Text] [Related]
31. Biphenabid (Probucol): a new hypocholesterolemic agent. Kalams Z; Dacquisto M; Kornett GS Curr Ther Res Clin Exp; 1971 Nov; 13(11):692-4. PubMed ID: 5000716 [No Abstract] [Full Text] [Related]
32. Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia. Heel RC; Brogden RN; Speight TM; Avery GS Drugs; 1978 Jun; 15(6):409-28. PubMed ID: 350557 [No Abstract] [Full Text] [Related]
33. Effect of probucol in hyperlipidemic patients during two years of administration. Parsons WB Am Heart J; 1978 Aug; 96(2):213-7. PubMed ID: 354360 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of individualized long-term therapy with niacin and probucol in reduction of serum cholesterol. Cohen L; Morgan J J Fam Pract; 1988 Feb; 26(2):145-50. PubMed ID: 3339318 [TBL] [Abstract][Full Text] [Related]
35. [Effect of probucol on serum cholesterol concentration in primary hyperlipoproteinemia]. Kawecka-Jaszcz K; Kocemba J; Wasowicz B; Król W Kardiol Pol; 1982; 25(5-6):377-82. PubMed ID: 6759746 [No Abstract] [Full Text] [Related]
36. Treatment with probucol of children with familial hypercholesterolaemia. Sanjurjo P; Martul P; Sasieta M; Lafuente P; Ariza F; Cabeza I Acta Paediatr Scand; 1988 Jan; 77(1):132-5. PubMed ID: 3285634 [TBL] [Abstract][Full Text] [Related]
37. A symposium: new developments in the treatment of hypercholesterolemia--probucol. Introduction. Eder HA Am J Cardiol; 1986 Jun; 57(16):1H-2H. PubMed ID: 3728304 [No Abstract] [Full Text] [Related]
38. Probucol treatment and thyroid function tests. Roach L; Botha A; Joffe BI; Baker SG; Shires R; Seftel HC S Afr Med J; 1980 Nov; 58(21):833. PubMed ID: 7444683 [No Abstract] [Full Text] [Related]
39. [Pharmacology of probucol. I]. Donatelli L Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074 [No Abstract] [Full Text] [Related]
40. [Probucol in the treatment of hyperlipidemias]. Feder D; Langer AL; Alexandrino E; Medeiros S; Lotto M; Valente O Arq Bras Cardiol; 1986 Feb; 46(2):77-80. PubMed ID: 3827649 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]